PHARMA Management Radar: Differentiated Supply Chains

Life Sciences companies are currently impacted by various trends that increase the complexity of their business, particularly in the supply chain area. The differentiation of supply chains might be a way out of the complexity trap. But what does the pharmaceutical industry think about this? Are differentiated supply chains seen as a suitable approach to master complexity?

The current 7th PHARMA Management Radar survey explores

  • which industry trends are the main drivers for an increasing complexity
  • whether and to what extent Life Sciences companies are already applying differentiation strategies to address complexity
  • in which areas and how comprehensively these strategies are applied or planned
  • what the most effective segmentation criteria and procedures for differentiated supply chains are.

In addition, the survey examines the general business climate in the Life Sciences industry.

Request Free Download

Our studies provide carefully prepared, valuable insights, which we are happy to share with you free of charge. We just ask you for a short registration.

By entering my data, I hereby declare that I agree and permit CAMELOT Management Consultants AG to contact me about the topic "PHARMA Management Radar: Differentiated Supply Chains"

In addition, I agree that my data may be used by CAMELOT Management Consultants AG and associated companies to inform me about service offerings, events, studies, or further activities. The user may revoke his declaration of consent at any time. In this case, please use the following link: https://www.camelot-mc.com/en/privacy-policy.